Featured Press Releases

Phanes Therapeutics

Phanes Therapeutics' PT217 receives FDA Fast Track Designation for neuroendocrine prostate cancer (NEPC)

Hyundai Bioscience Develops Multi-Treatment for Mosquito-Borne Viral Infections, Including Dengue Feve

Hyundai Bioscience Develops Multi-Treatment for Mosquito-Borne Viral Infections, Including Dengue Feve

  • 25 Jun 2024

Hyundai Bioscience (CEO Oh Sang-gi), which is preparing for a dengue fever basket clinical trial...

MAYPHARM CO., LTD. launches SKINCOLLA, the world

MAYPHARM CO., LTD. launches SKINCOLLA, the world's first recombinant human collagen filler for superior skin rejuvenation

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

Sai Life Sciences afslutter fase II af produktionsblok 11 på Bidar-stedet i Indien og øger kapaciteten til 700 KL

Sai Life Sciences afslutter fase II af produktionsblok 11 på Bidar-stedet i Indien og øger kapaciteten til 700 KL

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

  • SK bioscience
  • 03 Jun 2026
ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

  • Niagen Bioscience, Inc
  • 03 Jun 2026
AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

  • Medella Springs
  • 02 Jun 2026
Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

  • Seegene
  • 02 Jun 2026
Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

  • Ascensia Diabetes Care
  • 02 Jun 2026
XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

  • Shionogi USA
  • 01 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.